ClinicalTrialsFinder

Refractory Lupus Nephritis Clinical Trials in Guangzhou, Guangdomg

1 recruitingGuangzhou, Guangdomg, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis

Refractory Lupus NephritisRefractory Systemic Lupus Erythematosus
Guangdong Provincial People's Hospital18 enrolled1 locationNCT06676631